Line 272: | Line 272: | ||
</h4> | </h4> | ||
<h1 class="tag-title">Neil Donelan</h1> | <h1 class="tag-title">Neil Donelan</h1> | ||
− | <h4>Neil Donelan is an insurance assessor at the not-for-profit organisation Insulin for Life. He advised us on the issues relating to insulin transport internationally, informing our project design.</h4> | + | <h4>Neil Donelan is an insurance assessor at the not-for-profit organisation <a href=”https://www.insulinforlife.org.au/ |
+ | ”>Insulin for Life</a>. He advised us on the issues relating to insulin transport internationally, informing our project design.</h4> | ||
<h1 class="tag-title">Mike Nicholls</h1> | <h1 class="tag-title">Mike Nicholls</h1> | ||
− | <h4>Mike Nicholls is a Partner at Main Sequence Ventures, the $100m CSIRO Deep Tech Venture Capital Fund and Resident Entrepreneur at INCUBATE at The University of Sydney. Mike gave us advice about our entrepreneurship and the applied design of our project | + | <h4>Mike Nicholls is a Partner at <a href="https://mseq.vc/">Main Sequence Ventures</a>, the $100m CSIRO Deep Tech Venture Capital Fund and Resident Entrepreneur at INCUBATE at The University of Sydney. Mike gave us advice about our entrepreneurship and the applied design of our project |
</h4> | </h4> | ||
<h1 class="tag-title">Dr Narcyz Ghinea</h1> | <h1 class="tag-title">Dr Narcyz Ghinea</h1> |
Revision as of 02:00, 31 October 2017